Johnson Chemical Pharmaceutical Works Co Ltd - Asset Resilience Ratio
Johnson Chemical Pharmaceutical Works Co Ltd (4747) has an Asset Resilience Ratio of 4.89% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4747 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how Johnson Chemical Pharmaceutical Works Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Johnson Chemical Pharmaceutical Works Co asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Johnson Chemical Pharmaceutical Works Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 4747 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$102.30 Million | 4.89% |
| Total Liquid Assets | NT$102.30 Million | 4.89% |
Asset Resilience Insights
- Limited Liquidity: Johnson Chemical Pharmaceutical Works Co Ltd maintains only 4.89% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Johnson Chemical Pharmaceutical Works Co Ltd Industry Peers by Asset Resilience Ratio
Compare Johnson Chemical Pharmaceutical Works Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
Drug Manufacturers - Specialty & Generic | 0.35% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728 |
Drug Manufacturers - Specialty & Generic | 9.66% |
Annual Asset Resilience Ratio for Johnson Chemical Pharmaceutical Works Co Ltd (2025–2025)
The table below shows the annual Asset Resilience Ratio data for Johnson Chemical Pharmaceutical Works Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.89% | NT$102.30 Million ≈ $3.22 Million |
NT$2.09 Billion ≈ $65.97 Million |
-- |
About Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more